TABLE 9.

Clinical trials of resveratrol for respiratory conditions.

Condition	Phase	Subjects	Dose	Outcome	References
Common cold	III	89	Nasal solution of RSV/carboxymethyl-β-glucan	c β G/RSV treatment provided minor benefit for nasal symptoms in infants	Baldassarre et al., 2020
COPD	NA	21	150 mg/day 4 week	RSV treatment did not improve mitochondrial function in subjects with COPD	Beijers et al., 2020
Seasonal allergies	III	76	Nasal solution of RSV/carboxymethyl-β-glucan	c β G/RSV treatment reduced nasal symptoms	Miraglia Del Giudice et al., 2014
COPD	NA	48		Recruiting	NCT03819517
Cystic fibrosis	NA	36		Active, not recruiting	NCT04166396
COVID-19	II	100		Active, not recruiting	NCT04400890
COVID-19	II	60		Active, not recruiting	NCT04542993
COVID-19	NA	30		Recruiting	NCT04799743